Summer 2023 ACIP Update: RSV Prevention and Updated Recommendations on Other Vaccines
2023
· University of Colorado, · Children's National Hospital, · University of South Florida, More...
This article describes updates from the Advisory Committee on Immunization Practices (ACIP) about vaccines for children. It highlights new recommendations for using nirsevimab, a monoclonal …
Fall 2023 ACIP Update on Meningococcal, RSV, COVID-19, and Other Pediatric Vaccines
2024
· Children's National Hospital, · University of South Florida, · University of Alabama at Birmingham, More...
This article summarizes updates from the Advisory Committee on Immunization Practices (ACIP), a group advising the CDC, relevant to pediatrics, including recommendations for COVID-19 and …
Equitable Access to RSV Prevention: Challenges and Opportunities With Nirsevimab's Rollout
This editorial discusses challenges in achieving equal access to RSV prevention. This includes providing affordable vaccines, educating communities on prevention strategies, and implementing policies that …
Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season — New York City, 2023–2024
2024
· New York City Department of Health and Mental Hygiene,
· Centers for Disease Control and Prevention (CDC)
This analysis reviewed nirsevimab dosing based on Vaccines for Children (VFC) eligibility in New York City during the 2023–24 RSV season. A nirsevimab shortage in …
Childhood Immunization Discussion Guides
The American Academy of Pediatrics (AAP) provides helpful discussion guides for childhood immunizations on their webpage. These guides aim to assist parents and healthcare providers …
Recommended Childhood and Adolescent Immunization Schedule: United States, 2024
This policy statement describes the 2024 recommended childhood and adolescent immunization schedules, approved by multiple medical organizations including the CDC and AAP. Updates include the …
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
This article describes the use of nirsevimab, a new drug approved in 2023, to prevent severe respiratory syncytial virus (RSV) disease in infants and young …
Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of Nirsevimab, and Intent for Nirsevimab Receipt, United States [Dataset]
This dataset provides monthly estimates of infant protection against RSV that were calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM). The data …
Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024
This article is about a study on RSV vaccination for pregnant women and their babies in the U.S. It describes how RSV is a common …
Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt
2023
· Hôpital Antoine-Béclère AP-HP, · Université Paris-Saclay, · American College of Emergency Physicians, More...
This comment discusses the challenges of implementing universal infant immunization against respiratory syncytial virus (RSV) in Europe. RSV is a major cause of illness in …